JP2024540439A5 - - Google Patents

Info

Publication number
JP2024540439A5
JP2024540439A5 JP2024527790A JP2024527790A JP2024540439A5 JP 2024540439 A5 JP2024540439 A5 JP 2024540439A5 JP 2024527790 A JP2024527790 A JP 2024527790A JP 2024527790 A JP2024527790 A JP 2024527790A JP 2024540439 A5 JP2024540439 A5 JP 2024540439A5
Authority
JP
Japan
Application number
JP2024527790A
Other languages
Japanese (ja)
Other versions
JP2024540439A (ja
JPWO2023089328A5 (https=
Filing date
Publication date
Priority claimed from GBGB2116743.2A external-priority patent/GB202116743D0/en
Application filed filed Critical
Publication of JP2024540439A publication Critical patent/JP2024540439A/ja
Publication of JP2024540439A5 publication Critical patent/JP2024540439A5/ja
Publication of JPWO2023089328A5 publication Critical patent/JPWO2023089328A5/ja
Pending legal-status Critical Current

Links

JP2024527790A 2021-11-19 2022-11-18 叢状神経線維腫の治療又は予防に使用するためのニトロキソリン Pending JP2024540439A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2116743.2 2021-11-19
GBGB2116743.2A GB202116743D0 (en) 2021-11-19 2021-11-19 Treatment
PCT/GB2022/052933 WO2023089328A1 (en) 2021-11-19 2022-11-18 Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma

Publications (3)

Publication Number Publication Date
JP2024540439A JP2024540439A (ja) 2024-10-31
JP2024540439A5 true JP2024540439A5 (https=) 2025-11-17
JPWO2023089328A5 JPWO2023089328A5 (https=) 2025-11-17

Family

ID=79163954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527790A Pending JP2024540439A (ja) 2021-11-19 2022-11-18 叢状神経線維腫の治療又は予防に使用するためのニトロキソリン

Country Status (11)

Country Link
US (1) US20250000852A1 (https=)
EP (1) EP4433054A1 (https=)
JP (1) JP2024540439A (https=)
KR (1) KR20240108407A (https=)
CN (1) CN118215479A (https=)
AU (1) AU2022392456A1 (https=)
CA (1) CA3238805A1 (https=)
GB (1) GB202116743D0 (https=)
IL (1) IL312885A (https=)
MX (1) MX2024006105A (https=)
WO (1) WO2023089328A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202218460D0 (en) * 2022-12-08 2023-01-25 Healx Ltd Treatment
WO2026022492A1 (en) * 2024-07-26 2026-01-29 Healx Limited Nitroxoline for use in the treatment and/or prevention of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2641471T3 (es) * 2008-10-06 2017-11-10 The Johns Hopkins University Compuestos de quinolina como inhibidores de la angiogénesis, metionina aminopeptidasa humana, y SirT1, y procedimientos de tratamiento de trastornos
GB202108224D0 (en) * 2021-06-09 2021-07-21 Healx Ltd Treatment

Similar Documents

Publication Publication Date Title
JP2024540439A5 (https=)
JP2024520690A5 (https=)
CL2026000301A1 (es) Aparato para introducir un medio en un precursor alimenticio
CL2025004149A1 (es) Método y sistema para la recuperación de elementos valiosos a partir de la materia prima derivada de los relaves de minas de cobre.
CN307044322S (https=)
CN307045147S (https=)
CN307050035S (https=)
CN307049685S (https=)
CN307049372S (https=)
CN307048560S (https=)
CN307047913S (https=)
CN307047648S (https=)
CN307046245S (https=)
CN307046129S (https=)
CN307045696S (https=)
CN307045496S (https=)
CN307045235S (https=)
CN307044833S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)